Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Peregrine Pharmaceuticals drops sharply after halting study of potential lung cancer treatment
Peregrine Pharmaceuticals drops sharply after halting study of potential lung cancer treatment
Peregrine Pharmaceuticals drops sharply after halting study of potential lung cancer treatment
Submitted by
admin
on June 27, 2013 - 11:14am
Source:
Yahoo/AP
News Tags:
Peregrine Pharmaceuticals
lung cancer
bavituximab
Headline:
Peregrine Pharmaceuticals drops sharply after halting study of potential lung cancer treatment
Do Not Allow Advertisers to Use My Personal information
